Abstract |
Allan-Herndon-Dudley syndrome is an X-linked disease caused by mutations in the solute carrier family 16 member 2 (SLC16A2) gene. As SLC16A2 encodes the monocarboxylate transporter 8 (MCT8), a thyroid hormone transporter, patients with Allan-Herndon-Dudley syndrome present a specific altered thyroid hormone profile. Allan-Herndon-Dudley syndrome has been associated with myelination delay on the brain magnetic resonance imaging (MRI) of affected subjects. We report a patient with Allan-Herndon-Dudley syndrome characterized by developmental delay, hypotonia, and delayed myelination caused by a novel SLC16A2 mutation (p.L291R). The thyroid hormones profile in our patient was atypical for Allan-Herndon-Dudley syndrome. The follow-up examinations showed that the progression of the myelination was not accompanied by a clinical improvement. Our paper suggests that SLC16A2 mutations should be investigated in patients with myelination delay even when the thyroid function is not conclusively altered.
|
Authors | Roberta La Piana, Michel Vanasse, Bernard Brais, Genevieve Bernard |
Journal | Journal of child neurology
(J Child Neurol)
Vol. 30
Issue 10
Pg. 1371-4
(Sep 2015)
ISSN: 1708-8283 [Electronic] United States |
PMID | 25380603
(Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © The Author(s) 2014. |
Chemical References |
- Monocarboxylic Acid Transporters
- SLC16A2 protein, human
- Symporters
|
Topics |
- Brain
(growth & development, pathology)
- Canada
- Disease Progression
- Follow-Up Studies
- France
(ethnology)
- Humans
- Infant
- Magnetic Resonance Imaging
- Mental Retardation, X-Linked
(genetics, pathology, physiopathology)
- Monocarboxylic Acid Transporters
(genetics)
- Muscle Hypotonia
(genetics, pathology, physiopathology)
- Muscular Atrophy
(genetics, pathology, physiopathology)
- Mutation
- Myelin Sheath
(pathology, physiology)
- Symporters
- White People
(genetics)
|